Fertility and Sterility
Volume 94, Issue 5 , Pages 1707-1712 , October 2010

Analysis of 2,386 consecutive cycles of in vitro fertilization or intracytoplasmic sperm injection using autologous oocytes in women aged 40 years and above

  • Gamal Serour, M.D.

      Affiliations

    • Al Azhar University, Cairo, Egypt
    • Egyptian IVF and ET Center, Cairo, Egypt
    • Corresponding Author InformationReprint requests: Gamal Serour, M.D., 3 St. 161 Hadaek El-Maadi, Cairo, Egypt (FAX: 002-02-25754271).
    • ,
  • Ragaa Mansour, Ph.D.

      Affiliations

    • Egyptian IVF and ET Center, Cairo, Egypt
    • ,
  • Ahmed Serour, M.D.

      Affiliations

    • Al Azhar University, Cairo, Egypt
    • Egyptian IVF and ET Center, Cairo, Egypt
    • ,
  • Mona Aboulghar, M.D.

      Affiliations

    • Egyptian IVF and ET Center, Cairo, Egypt
    • ,
  • Yahia Amin, M.D.

      Affiliations

    • Egyptian IVF and ET Center, Cairo, Egypt
    • ,
  • Omnia Kamal, B.S.

      Affiliations

    • Egyptian IVF and ET Center, Cairo, Egypt
    • ,
  • Hesham Al-Inany, M.D.

      Affiliations

    • Egyptian IVF and ET Center, Cairo, Egypt
    • ,
  • Mohamed Aboulghar, M.D.

      Affiliations

    • Egyptian IVF and ET Center, Cairo, Egypt

Received 27 July 2009 ,Revised 14 September 2009 ,Accepted 18 September 2009.

References 

  1. Speroff L, Fritz MA. Clinical gynecologic endocrinology and infertility. 6th ed.. Philadelphia: Lippincott Williams & Wilkins; 2004;
  2. U.S. National Center for Health Statistics . Health and Injury Chartbook. In: US National Center for Health Statistics, National Vital Statistics Report. Vol. 50, No. 7. Hyattsville, MD: Centers for Disease Control and Prevention; 2002;Available at http://www.cdc.gov/nchs/data/NVSR/ nvsr50/nvsr50 07.pdf
  3. Center for Disease Control and Prevention . American Society for Reproductive Medicine, Society for Assisted Reproductive Technology, RESOLVE. 1999 Assisted reproductive technology success rates. Atlanta, GA: Centers for Disease Control and Prevention; 2001;
  4. Andersen AN, Goossens V, Bhattacharya S, Ferraretti AP, Kupka MS, de Mouzon J, et al. Assisted reproductive technology and intrauterine insemination in Europe, 2005: results generated from European registers by ESHRE. Hum Reprod. 2009;24:1267–1287
  5. Mansour RT, Abou-Setta AM. Results of assisted reproductive technology in 2001 generated from the Middle East IVF registry. Middle East Fertil Soc J. 2006;11:145–151
  6. Tsafrir A, Simon A, Revel A, Reubinoff B, Lewin A, Laufer N. Retrospective analysis of 1217 IVF cycles in women aged 40 years and older. Reprod Biomed Online. 2007;14:348–355
  7. Baird DT, Collins J, Egozcue J, Evers LH, Gianaroli L, Leridon H, et al. Fertility and aging. ESHRE Capri Workshop Group. Hum Reprod Update. 2005;11:261–276
  8. Hull MG, Fleming CF, Hughes AO, McDermott A. The age-related decline in female fecundity: a quantitative controlled study of implanting capacity and survival of individual embryos after in vitro fertilization. Fertile Steril. 1996;65:783–790
  9. Vialard F, Lombroso R, Bergere M, Molina Gomes D, Hammoud I, Bailly M, et al. Oocyte aneuploidy mechanisms are different in two situations of increased chromosomal risk: older patients and patients with recurrent implantation failure after in vitro fertilization. Fertil Steril. 2007;87:1333–1339
  10. Practice Committee of the American Society for Reproductive Medicine . Aging and infertility in women. Fertil Steril. 2006;86(Suppl 4):S248–S252
  11. Broekman FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12:685–718
  12. Fauser B, Diedrich K, Devroey P Evian Annual Reproduction (EVAR) Workshop Group. Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation. Hum Reprod Update. 2008;14:1–14
  13. Paulsen RJ, Boostanfar R, Saadat P, Mor E, Tourgeman D, Slater CC, et al. Pregnancy in the sixth decade of life obstetric outcomes in women of advanced reproductive age. JAMA. 2002;288:2320–2323
  14. Serour GI. Islamic perspectives in human reproduction: ethical issues in ART. Reprod Biomed Online. 2008;17(Suppl 3):34–38
  15. Serour GI. Medical and socio-cultural aspects of infertility in the Middle East. ESHRE Monogr. 2008;1:34–41
  16. Silber SJ, DeRosa M, Pineda J, Lenahan K, Grenia D, Gorman K, et al. A series of monozygotic twins discordant for ovarian failure: ovary transplantation (cortical versus microvascular) and cryopreservation. Hum Reprod. 2008;23:1531–1537
  17. Silber SJ, Grudzinskas G, Gosden RG. Successful pregnancy after microsurgical transplantation of an intact ovary. N Engl J Med. 2008;359:2617–2618
  18. Lamar CA, Decherney AH. Fertility preservation: state of the science and future research directions. Fertil Steril. 2009;91:316–319
  19. Aboulghar MA, Mansour RT, Serour GI, Fahmy J, Kamal A, Tawab NA. Fertilization and pregnancy rates after intracytoplasmic sperm injection using ejaculate semen and surgically retrieved sperm. Fertil Steril. 1997;68:108–111
  20. Serour GI, Aboulghar M, Mansour R, Sattar MA, Amin Y, Aboulghar H. Complications of medically assisted conception in 3,500 cycles. Fertil Steril. 1998;70:638–642
  21. Mansour R, Fahmy I, Tawab NA, Kamal A, El Demery Y, Aboulghar M, et al. Electrical activation of oocytes after intracytoplasmic sperm injection: a controlled randomized study. Fertil Steril. 2009;91:133–139
  22. Practice Committee . Society for Assisted Reproductive Medicine and the American Society for Reproductive Medicine. Guidelines on the number of embryos transferred: a practice committee report. Fertil Steril. 2004;82:772–774
  23. Aboulghar M, Amin Y, Al-Inany HG, Aboulghar MM, Serour GI, Mansour RT. Prospective randomized study comparing luteal phase support for ICSI patients up to the first ultrasound compared with and additional three weeks. Hum Reprod. 2008;23:857–862
  24. Kagawa N, Silber S, Kuwayama M. Successful vitrification of bovine and human ovarian tissue. Reprod Biomed Online. 2009;18:568–577
  25. ESHRE Task Force on Ethics and Law . Task Force 7: ethical considerations for the cryopreservation of gametes and reproductive tissues for self use. Hum Reprod. 2004;19:460–462
  26. FIGO Committee for the Ethical Aspects of Human Reproduction and Women's Health . Ethical considerations and recommendations on oocyte and ovarian cryopreservation. Int J Gynecol Obstet. 2006;92:335–336
  27. Practice Committee of the American Society of Reproductive Medicine . Essential elements of informed consent for elective oocyte cryopreservation: a practice committee opinion. Fertil Steril. 2007;88:1495–1496
  28. Tietze C. Reproductive span and rate of reproduction among Hutterite women. Fertil Steril. 1957;8:89–97
  29. Laufer N, Simon A, Samueloff A, Yaffe H, Milwidsky A, Gielehinsky Y. Successful spontaneous pregnancies in women older than 45 years. Fertil Steril. 2004;81:1328–1332
  30. Lass A, Croucher C, Duffy S, Dawson K, Margara R, Winston RM. One thousand initiated cycles of in vitro fertilization in women >40 years of age. Fertil Steril. 1998;70:1030–1034
  31. Klipstein S, Regan M, Ryley DA, Goldman MB, Alper MM, Reindollar RH. One last chance for pregnancy: a review of 2,705 in vitro fertilization cycles initiated in women age 40 years and above. Fertil Steril. 2005;84:435–445
  32. Wang A, Healy D, Black D, Sullivan EA. Age-specific success rate for women undertaking their first assisted reproduction technology treatment using their own oocytes in Australia, 2002–2005. Hum Reprod. 2008;23:1633–1638
  33. UNFPA State of the World Population 2008 . Reaching common ground: culture, gender and human rights. Geneva: United Nations; 2009;
  34. Henne MB, Stegmann BJ, Neithardt AB, Catherino WH, Armstrong AY, Segars JH. The combined effect of age and basal follicle-stimulating hormone on the cost of a live birth at assisted reproductive technology. Fertil Steril. 2008;89:104–110
  35. Homburg R, Veen FV, Silber SJ. Oocyte vitrification women's emancipation set in stone. Fertil Steril. 2009;91:1419–1420
  36. FIGO Committee for the Ethical Aspects of Human Reproduction and Women's Health . Ethical guidelines on conscientious objection. Int J Gynecol Obstet. 2006;92:333–334

 G.S. has nothing to disclose. R.M. has nothing to disclose. A.S. has nothing to disclose. M.A. has nothing to disclose. Y.A. has nothing to disclose. O.K. has nothing to disclose. H.A. has nothing to disclose. M.A. has nothing to disclose.

PII: S0015-0282(09)03793-5

doi: 10.1016/j.fertnstert.2009.09.044

Fertility and Sterility
Volume 94, Issue 5 , Pages 1707-1712 , October 2010

Article Tools

* Image Usage & Resolution